Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial

The AmbOx trial provides RCT evidence for ambulatory oxygen therapy improving HRQoL in patients with fibrotic ILD http://ow.ly/uHC030nEzsz

Gardado en:
Detalles Bibliográficos
Publicado en:Breathe (Sheff)
Main Authors: Creamer, Andrew W., Barratt, Shaney L.
Formato: Artigo
Idioma:Inglês
Publicado: European Respiratory Society 2019
Assuntos:
Expert Opinion
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544787/
https://ncbi.nlm.nih.gov/pubmed/31191728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0002-2019
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares